Dingell Holds Roundtable with Michigan Medicine to Discuss National Chemotherapy Drug Shortage
Congresswoman Debbie Dingell (MI-06) today held a roundtable with Michigan Medicine to discuss the impacts of and potential solutions to the cancer drug shortage affecting patients and health systems across the country. The discussion included participants from Michigan Medicine’s Rogel Cancer Center, Department of Pharmacy Services, and Center for Bioethics and Social Sciences.
“We have a serious drug shortage in this country that’s leaving thousands of patients in Michigan and across the nation in distress,” Dingell said.
“It is an unimaginable feeling to tell a patient with cancer that there is a lifesaving medicine for them that costs less than a tank of gasoline, but that it is not available for reasons out of all our control,” said Andrew Shuman, M.D., FACS, HEC-C, chief of the clinical ethics service in Michigan Medicine’s Center for Bioethics and Social Sciences. “Michigan Medicine invests massive effort into ensuring our supply of scarce medications is sufficient for our patients, but many facilities are not so well resourced. We thank Representative Dingell for her commitment to addressing this challenge and welcome needed legislative changes.”
Read the full press release here.
